- Home
- GIGM vs IGC Comparison
GIGM vs IGC Comparison
Compare GIGM & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIGM
- IGC
- Stock Information
- Founded
- GIGM 1998
- IGC 2005
- Country
- GIGM Taiwan
- IGC United States
- Employees
- GIGM N/A
- IGC N/A
- Industry
- GIGM Computer Software: Programming Data Processing
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- GIGM Technology
- IGC Health Care
- Exchange
- GIGM Nasdaq
- IGC Nasdaq
- Market Cap
- GIGM 17.0M
- IGC 18.0M
- IPO Year
- GIGM 2000
- IGC N/A
- Fundamental
- Price
- GIGM $1.60
- IGC $0.30
- Analyst Decision
- GIGM
- IGC Strong Buy
- Analyst Count
- GIGM 0
- IGC 2
- Target Price
- GIGM N/A
- IGC $3.88
- AVG Volume (30 Days)
- GIGM 17.9K
- IGC 261.6K
- Earning Date
- GIGM 05-02-2025
- IGC 02-18-2025
- Dividend Yield
- GIGM N/A
- IGC N/A
- EPS Growth
- GIGM N/A
- IGC N/A
- EPS
- GIGM N/A
- IGC N/A
- Revenue
- GIGM $2,969,000.00
- IGC $1,236,000.00
- Revenue This Year
- GIGM N/A
- IGC N/A
- Revenue Next Year
- GIGM N/A
- IGC $18.34
- P/E Ratio
- GIGM N/A
- IGC N/A
- Revenue Growth
- GIGM N/A
- IGC 1.65
- 52 Week Low
- GIGM $1.26
- IGC $0.25
- 52 Week High
- GIGM $1.80
- IGC $0.63
- Technical
- Relative Strength Index (RSI)
- GIGM 51.62
- IGC 53.06
- Support Level
- GIGM $1.52
- IGC $0.27
- Resistance Level
- GIGM $1.61
- IGC $0.30
- Average True Range (ATR)
- GIGM 0.04
- IGC 0.02
- MACD
- GIGM 0.00
- IGC 0.00
- Stochastic Oscillator
- GIGM 80.10
- IGC 69.74
About GIGM GigaMedia Limited
GigaMedia Ltd is a publisher of online games. It has only one reportable segment, Digital Entertainment service. Digital Entertainment service business operates a portfolio of online games, mainly targeting online game players across Europe, and Asia, including Greater China and Southeast Asia. The company's portfolio of online games includes predominantly PC-based, non-cash gambling, or casino casual games, including MahJong and various card and table games. The company's product lines include MahJong, AkaSeka, Yume 100, Fun Vegas, and others. The company operates in Taiwan and Hong Kong.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.